Liminal BioSciences DSO Ratio 2011-2026 | LMNL

Annual DSO Ratio Liminal BioSciences

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	429	990	296	102	196	125	201	249	229	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
990	102	313

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Amarin Corporation plc AMRN	213	$ 14.67	-0.07 %	$ 6.09 B	Irlanda
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
CEL-SCI Corporation CVM	227	$ 3.47	-1.7 %	$ 221 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Denali Therapeutics DNLI	1.89	$ 19.74	-12.17 %	$ 3.25 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Equillium EQ	16.6	$ 2.06	-	$ 118 M	USA
Esperion Therapeutics ESPR	99.7	$ 2.85	3.26 %	$ 592 M	USA
Eton Pharmaceuticals ETON	39.1	$ 23.45	-1.64 %	$ 631 M	USA
China SXT Pharmaceuticals SXTC	318	$ 1.32	-5.2 %	$ 1.88 M	China
CRISPR Therapeutics AG CRSP	1.1 K	$ 47.55	0.98 %	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	50	$ 4.45	-1.77 %	$ 853 M	Canada